Device Trial Radar · NCT06431061
Clinical Evaluation of Proclear Toric and Biofinity Toric
Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jun 4, 2024
Primary completion
Nov 13, 2024
Study completion Nov 13, 2024
Sponsor
- Lead sponsor
- CooperVision, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Centre for Ocular Research & Education, Canada
- First posted
- May 28, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to compare the short-term clinical performance of two Toric contact lenses.
Conditions
- Astigmatism
Interventions
Lens A (omafilcon B)Device
15 minutes of daily wear.
Lens B (comfilcon A)Device
15 minutes of daily wear.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Fit AcceptanceTime frame: After 15 minutes of continuous wear
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Waterloo
Waterloo, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.